Skip to main content

and
  1. Article

    Open Access

    Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability

    Metabolic programs can differ substantially across genetically distinct subtypes of acute myeloid leukemia (AML). These programs are not static entities but can change swiftly as a consequence of extracellular...

    Ayşegül Erdem, Silvia Marin, Diego A. Pereira-Martins in Nature Communications (2022)

  2. Article

    Open Access

    The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia

    Acute myeloid leukemia remains difficult to treat due to strong genetic heterogeneity between and within individual patients. Here, we show that Pyruvate dehydrogenase kinase 1 (PDK1) acts as a targetable dete...

    Ayşegül Erdem, Silvia Marin, Diego A. Pereira-Martins in Nature Communications (2022)

  3. Article

    Open Access

    HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cells

    Hypoxia-inducible factors (HIF)1 and 2 are transcription factors that regulate the homeostatic response to low oxygen conditions. Since data related to the importance of HIF1 and 2 in hematopoietic stem and pr...

    Albertus T. J. Wierenga, Alan Cunningham, Ayşegül Erdem in Cancer & Metabolism (2019)

  4. No Access

    Article

    Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors

    Loss-of-function mutations of cyclic-AMP response element binding protein, binding protein (CREBBP) are prevalent in lymphoid malignancies. However, the tumour suppressor functions of CREBBP remain unclear. We...

    Sarah J. Horton, George Giotopoulos, Haiyang Yun, Shabana Vohra in Nature Cell Biology (2017)